Literature DB >> 15791849

Expression and clinical significance of p27kip1 protein in primary liver cancer.

Guangjun Shi1, Peng Yang, Xiaoping Chen.   

Abstract

To investigate the expression and clinical significance of p27kip1 protein in primary liver cancer, the expression of p27kip1 protein and the relationship with clinicopathological factors were studied in primary liver cancer by using SABC immunohistochemical staining in specimens of 40 cases of primary liver cancer and 20 cases of liver cirrihosis. Our results showed that positive expression rate of p27kip1 protein in primary liver cancer was 37.5% (15/40), which was lower than that in benign lesion of liver 80.0% (16/20, P<0.01). The expression level of p27kip1 protein in primary liver cancer showed significant differences in tumor size, Edmonson histological grade, portal invasion, lymph node metastasis, TNM stage (P<0.05, for all), but not significantly correlated with patient's age and histological types. Log rank test showed that the p27kip1 expression was significantly related with prognosis of the patients (P<0.05), and the prognosis of the patients with p27kip1 positive expression was markedly better than that of those with p27kip1 negative expression. It is concluded that the expression of p27kip1 was significantly related clinicopathological factors of primary liver cancer. p27kip1 protein may be used as a novel tumor marker for primary liver cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15791849     DOI: 10.1007/BF02911363

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

Authors:  L Jin; X Qian; E Kulig; N Sanno; B W Scheithauer; K Kovacs; W F Young; R V Lloyd
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Aberrant p27kip1 expression in endocrine and other tumors.

Authors:  R V Lloyd; L Jin; X Qian; E Kulig
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

4.  The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

Authors:  P Tan; B Cady; M Wanner; P Worland; B Cukor; C Magi-Galluzzi; P Lavin; G Draetta; M Pagano; M Loda
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

5.  Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma.

Authors:  H Mineta; K Miura; I Suzuki; S Takebayashi; H Amano; K Araki; H Harada; K Ichimura; J P Wennerberg; M R Dictor
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

6.  Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.

Authors:  A M Hui; X Cui; M Makuuchi; X Li; Y Z Shi; T Takayama
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

7.  Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.

Authors:  M Ciaparrone; H Yamamoto; Y Yao; A Sgambato; G Cattoretti; N Tomita; T Monden; H Rotterdam; I B Weinstein
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.